What is the latest published ABT stock rating?

Abbott Laboratories is shown with Reduce in the latest published report, analyzed 2026-09-09. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ABT analysis?

The full latest published report, analyzed 2026-09-09, lives at /stocks/ABT/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for ABT?

The latest published report analyzed 2026-09-09 gives ABT a fair value of USD 87 and a potential value of USD 140. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the ABT page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-09-09). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

ABT Stock: Fundamentals & Analysis | StockMarketAgent.AI

تسجيل الدخول Start free

Abbott Laboratories (ABT)

NYSE: ABT · USD

—

StockMarketAgent Research · Analyzed 2026-09-09

Our latest published analysis: ABT rated Reduce

Abbott Laboratories's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$86.7 / share

Potential value

$140 / share

Upside to FV

-17.8%

Moat

1/10

None

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$183.8B
P/E (forward)	17.9x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

P/E (forward): 17.9x
Market cap: $183.8B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$43.08B	$43.65B	$40.11B	$41.95B	$44.33B	+0.7%
Gross profit	$23.21B	$22.32B	$20.04B	$21.33B	$24.61B	+1.5%
Operating income	$8.43B	$8.36B	$6.48B	$6.83B	$8.05B	-1.1%
Net income	$7.07B	$6.93B	$5.72B	$13.40B	$6.52B	-2.0%
EPS (diluted)	$3.94	$3.91	$3.26	$7.64	$3.72	-1.4%
EBITDA	$12.16B	$11.89B	$10.61B	$10.83B	$11.55B	-1.3%
R&D	$2.74B	$2.89B	$2.74B	$2.84B	$2.94B	+1.8%
SG&A	$11.32B	$11.25B	$10.95B	$11.70B	$12.33B	+2.2%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	—	—	—	—	—	—	بيع
ACN	Accenture plc	—	—	—	—	—	—	احتفاظ
ADI	Analog Devices, Inc.	—	—	—	—	—	—	بيع
ALGN	Align Technology Inc.	—	—	—	—	—	—	تخفيض
ALNY	Alnylam Pharmaceuticals, Inc.	—	—	—	—	—	—	شراء قوي
AMGN	Amgen Inc.	—	—	—	—	—	—	شراء

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($86.74). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	1.5%	2.0%	2.5%	3.0%	3.5%
5.3%	$99.9	$106	$115	$127	$146
6.3%	$87.9	$91.7	$96.6	$103	$111
7.3%	$79.6	$82.1	$86.7	$88.8	$93.4
8.3%	$73.4	$75.2	$77.2	$79.6	$82.5
9.3%	$68.7	$69.9	$71.4	$73.0	$74.9

Scorecard

Published factor rows and weighted composite

Valuation3.0

Management6.5

Balance Sheet6.0

Profitability5.5

Revenue Growth6.0

Risk Assessment7.5

Competitive Moat1.0

Earnings Quality6.0

Capital Efficiency5.5

Weighted composite

5.2/10

Mixed

Category	Score	Reading
Valuation	3.0
Management	6.5
Balance Sheet	6.0
Profitability	5.5
Revenue Growth	6.0
Risk Assessment	7.5
Competitive Moat	1.0
Earnings Quality	6.0
Capital Efficiency	5.5

سجل التصنيفات

التصنيف الذي حملته نسخة البحث المنشورة في كل شهر. يقارن التصنيف السعر في تاريخ التحليل بالقيمة العادلة، وليس سجلاً لمدى صحة التقدير.

السنة	يناير	فبراير	مارس	أبريل	مايو	يونيو	يوليو	أغسطس	سبتمبر	أكتوبر	نوفمبر	ديسمبر
2026

شراء قوي
تخفيض

Abbott Laboratories (ABT)

Our latest published analysis: ABT rated Reduce

Price

Financial snapshot

Fair-value bridge

Latest news · ABT

Valuation

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

Deeper analysis on ABT

Frequently asked questions

سجل التصنيفات